Table 4.
Predictor Variables | Points Assigned | Total Point Score | Probability of 1-Year PFS |
476 | 0.01 | ||
Gender | 437 | 0.05 | |
413 | 0.10 | ||
Male | 0 | 381 | 0.20 |
Female | 68 | 354 | 0.30 |
ECOG | 329 | 0.40 | |
304 | 0.50 | ||
0 | 0 | 276 | 0.60 |
1/2 | 14 | 243 | 0.70 |
3 | 98 | 200 | 0.80 |
Platelet/lymphocyte ratio | 132 | 0.90 | |
66 | 0.95 | ||
≤270 | 0 | Total point score | Probability of 2-year PFS |
>270 | 48 | 424 | 0.01 |
Sarcopenia | 385 | 0.05 | |
361 | 0.10 | ||
Yes | 77 | 328 | 0.20 |
No | 0 | 301 | 0.30 |
Metastatic site | 277 | 0.40 | |
251 | 0.50 | ||
Non-liver | 0 | 223 | 0.60 |
Liver | 74 | 191 | 0.70 |
Sunitinib dose (mg) | 148 | 0.80 | |
79 | 0.90 | ||
25 | 72 | 14 | 0.95 |
37.5 | 81 | Total point score | Probability of 3-year PFS |
50 | 0 | 387 | 0.01 |
Hypertension | 348 | 0.05 | |
324 | 0.10 | ||
No | 78 | 292 | 0.20 |
Yes | 0 | 265 | 0.30 |
Hand–foot syndrome | 240 | 0.40 | |
215 | 0.50 | ||
No | 100 | 187 | 0.60 |
Yes | 0 | 154 | 0.70 |
112 | 0.80 | ||
43 | 0.90 |